Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats

Indian Journal of Pharmacology

Volumn 45, Issue 2, 2013, Pages 174-179

  Peng, Sheng Nan ^a,b   Zeng, Hui Hong ^a   Fu, Ai Xiang ^a   Chen, Xiao Wen ^a   Zhu, Qing Xian ^a  

^a NANCHANG UNIVERSITY   (China)

^b Traditional Chinese Medicine College   (China)

Author keywords

IgA nephropathy; rat; rhein

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN; IMMUNOGLOBULIN A; RHEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; EXCRETION; EXTRACELLULAR MATRIX; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY HYPERTROPHY; KIDNEY PARENCHYMA; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL CAPSULE DILATION; RENAL PROTECTION; TREATMENT DURATION; URINALYSIS; URINE VOLUME;

IGA NEPHROPATHY; RAT; RHEIN;

ACTINS; ANIMALS; ANTHRAQUINONES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; FIBRONECTINS; GLOMERULONEPHRITIS, IGA; KIDNEY GLOMERULUS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84875974771     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.108309     Document Type: Article

References (25)

1. Floege J. The pathogenesis of IgA nephropathy: What is new and how does it change therapeutic approaches? Am J Kidney Dis 2011;58:992-1004
2. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005;16:2088-97
3. Ina K, Kitamura H, Tatsukawa S, Fujikura Y. Significance of 〈-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis. Histol Histopathol 2011;26:855-66
4. Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Exp Clin Endocrinol Diabetes 2007;115:571-6
5. Zheng JM, Zhu JM, Li LS, Liu ZH. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol 2008;153:1456-64
6. He D, Lee L, Yang J, Wang X. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy. Biol Pharm Bull 2011;34:1219-26
7. Tang Y, Lou TQ, Cheng CL, Peng H, Guan WM. Improvement of experimental IgA nephropathy model. J Sun Yat-sen University (Medical Sciences) 2006;27:184-7
8. Guo MZ, Li XS, Xu HR, Mei ZC, Shen W, Ye XF. Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats. Acta Pharmacol Sin 2002;23:739-44
9. Hatakeyama K, Wakabayashi-Nakao K, Aoki Y, Ogura S, Yamaguchi K, Nakajima T, et al. Novel protein extraction approach using micro-sized chamber for evaluation of proteins eluted from formalin-fixed paraffin-embedded tissue sections. Proteome Sci 2012;10:19
10. Zhang L, Ye F, He Y, Kong D, Han C, Zhao Z, et al. Establishment of a mouse IgA nephropathy model with the MBP-20-peptide fusion protein. Anat Rec (Hoboken) 2010;293:1729-37
11. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: A retrospective study. Am J Kidney Dis 2007;49:763-75
12. Gao Q, Qin WS, Jia ZH, Zheng JM, Zeng CH, Li LS, et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med 2010;76:27-33
13. Lim BJ, Kim JH, Hong SW, Jeong HJ. Expression of fibrosis-Associated molecules in IgA nephropathy treated with cyclosporine. Pediatr Nephrol 2009;24:513-9
14. Pavan MV, Ghini B, Castro M, Lopes De Faria JB. Prevention of hypertension attenuates albuminuria and renal expression of fibronectin in diabetic spontaneously hypertensive rats. Am J Nephrol 2003;23:422-8
15. Zhang L, Pang S, Deng B, Qian L, Chen J, Zou J, et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/ NF-|B/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int J Biochem Cell Biol 2012;44:629-38
16. Singh AP, Singh AJ, Singh N. Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats. Indian J Pharmacol 2011;43:551-6
17. Liu ZH, Li YJ, Chen ZH, Liu D, Li LS. Glucose transporter in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein. Acta Pharmacol Sin 2001;22:169-75
18. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006;17:2992-8
19. Alexopoulos E, Gionanlis L, Papayianni E, Kokolina E, Leontsini M, Memmos D. Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 2006;7:16
20. Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 2009;175:1371-3
21. Järvinen PM, Laiho M. LIM-domain proteins in transforming growth factor ®-induced epithelial-To-mesenchymal transition and myofibroblast differentiation. Cell Signal 2012;24:819-25
22. Minz R, Bakshi A, Chhabra S, Joshi K, Sakhuja V. Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction. Indian J Nephrol 2010;20:34-9
23. Chai JJ, Chen YP, Rui HL. Effects of Hirsutella sinensis on TGF-beta1 and Snail expressions and transdifferentiation of tubular epithelial-myofibroblast in renal tissue of rats with chronic aristolochic acid nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009;29:325-9
24. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, et al. Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers. Kidney Int 2004;66:1606-12
25. Cirillo M. Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 2010;23:125-32